Scientists outline stategy for AIDS cure

HIV-1
HIV-1 Virus. Credit: J Roberto Trujillo/Wikipedia
Calling the AIDS epidemic "the most important global health challenge in modern history," more than 50 top scientists pressed their case Monday for a drive to stop the killer disease in its tracks.

Anchored by Nobel Medicine laureate Francoise Barre-Sinoussi, the group unveiled an aggressive research strategy for an outright cure—an objective once seen as unrealistic and out of reach.

"Not long ago, few considered the possibility that a cure for HIV infection could some day be possible," said Barre-Sinoussi, who in 1983 helped identify the mysterious virus that causes AIDS.

Today, "the search for a cure has become a top priority in HIV research," she said in a statement, hailing a "new optimism" among experts.

The blueprint is published in the journal Nature Medicine ahead of a meeting of specialists on July 18-22 at the 21st International AIDS Conference in Durban, South Africa.

The scientists take stock of many recent gains in treating the (HIV), but argue that the solution for ending the pandemic lies in a cure.

In 2004, AIDS deaths peaked at more than two million.

Last year, the toll was around 1.2 million lives—a decline attributed in large part to the success of anti-retroviral (ART) drugs, which reduce the symptoms of people carrying the virus.

'Daunting' situation

But less than half of an estimated 37 million people worldwide living with HIV receive therapy.

Helping them to grasp that lifeline will require a huge, lifelong commitment. On top of that, the powerful drugs can have toxic side-effects.

Those problems are "daunting" and the economic costs "might be unsustainable," the strategy warned.

As a result, preventing and destroying the virus should be top priorities.

On the prevention scoreboard, experimental vaccines show promise, but are probably years away.

As for eradication, scientists understand far better now how HIV remains barricaded in tissues—such as the lymph nodes and the gut—after being beaten back by ART therapy, the standard drug cocktail given to HIV patients.

Research has found starting ART therapy early limits the ability of the virus to establish a redoubt.

The scientists also outline an array of tactics for identifying how the virus tucks itself away inside the human body, and methods for flushing it out and killing it.

But, they say, "the challenges... remain substantial," and there are still many pieces missing in the puzzle.

One prime target is so-called CD4-plus T cells.

These play a central role in the body's immune system, which defends against viral and microbial intruders.

HIV finds secret hideaways in long-lived "memory" versions of these cells, but how the virus does this is not fully understood.

Another objective is to strengthen the immune system.

Foot-soldiers known as "broadly neutralising antibodies" may be able to recognise these latently-infected cells, and then call on specialised "killer" cells to destroy them.

Better lab tools are needed, the scientists added, for measuring HIV persistence.

A common idea is that HIV only needs a few CD4-plus T cells to hideout. But sequencing of viral genomes suggest the disease's reservoir could be much larger.

Barre-Sinoussi launched the cure initiative in 2010 among a small group of scientists, some of whom were doubtful that eradicating HIV—as opposed to holding it in check—was feasible.

Two years later, the group developed its first long-term strategy, which is now being updated.

Global investment in finding a cure has risen from $88 million (80 million euros) in 2012 to $202 million (183 million euros) in 2015, most of which came from the US government.


Explore further

Study observes potential breakthrough in treatment of HIV

More information: International AIDS Society global scientific strategy: towards an HIV cure 2016, Nature Medicine, DOI: 10.1038/nm.4108
Journal information: Nature Medicine

© 2016 AFP

Citation: Scientists outline stategy for AIDS cure (2016, July 11) retrieved 26 June 2019 from https://medicalxpress.com/news/2016-07-scientists-outline-stategy-aids.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
143 shares

Feedback to editors

User comments

Jul 11, 2016
AIDS/HIV needs a "Reverse Transcriptase" Protein Enzyme to replicate and or reproduce itself, which is known by scientists. In 2005-2009 scientists proved "Olive Leaf Extract" did inhibit, or stop the reproduction of this protein enzyme needed by the AIDS/HIV Virus to reproduce itself. However, that information is not public because the actual cure cost pennies on the dollar and cannot be patented. Look up the info for yourself, if you are truly seeking the Truth about AIDS/HIV.
Ref:
1. Politics in Healing: The Suppression and Manipulation of American Medicine by Daniel Haley
2. The Persecution and trial of Gaston Naessens
3. DVD, The Strecker Memorandum, Robert B. Strecker MD, PhD.
4. Olive Leaf Extract, by Morton Walker.
5. Smallpox Vaccine "Triggered AIDS Virus", Pearce Wright, Science Editor, London Times, Monday May 11, 1987

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more